Skip to content

Akcea Therapeutics, Inc.

CIK 0001662524

← back to feed
Revenue (TTM)
$85.7M
+1,245.4% YoY Q2 Jul 2020
Net Income (TTM)
−$161.25M
+361.6% YoY Q2 Jul 2020
EPS Diluted (TTM)
—
Q2 Jul 2020
Gross Margin
—
Q2 Jul 2020
Operating Margin
-195.6%
Q2 Jul 2020
Net Margin
-188.2%
Q2 Jul 2020
Free Cash Flow (TTM)
$42.3M
Q2 Jul 2020
Cash
$135.74M
Q2 Jul 2020
Total Debt
—
Q2 Jul 2020
Shares Outstanding
101.6M sh
Q2 Jul 2020

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings